Oragenics, Inc. (OGEN)

USD 0.19

(8.7%)

Long Term Debt Summary of Oragenics, Inc.

  • Oragenics, Inc.'s latest annual long term debt in 2023 was - USD , down -100.0% from previous year.
  • Oragenics, Inc.'s latest quarterly long term debt in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Oragenics, Inc. reported annual long term debt of 152.43 Thousand USD in 2022, down -49.11% from previous year.
  • Oragenics, Inc. reported annual long term debt of 299.52 Thousand USD in 2021, down -39.34% from previous year.
  • Oragenics, Inc. reported quarterly long term debt of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Oragenics, Inc. reported quarterly long term debt of - USD for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Oragenics, Inc. (2023 - 2003)

Created with Highcharts 11.1.0YearsLong Term Debt20042006200820102012201420162018202020220 USD200000 USD400000 USD600000 USD800000 USD

Historical Annual Long Term Debt of Oragenics, Inc. (2023 - 2003)

Year Long Term Debt Long Term Debt Growth
2023 - USD -100.0%
2022 152.43 Thousand USD -49.11%
2021 299.52 Thousand USD -39.34%
2020 493.79 Thousand USD -26.38%
2019 670.69 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%

Peer Long Term Debt Comparison of Oragenics, Inc.

Name Long Term Debt Long Term Debt Difference
AIM ImmunoTech Inc. 495 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. - USD NaN%
Armata Pharmaceuticals, Inc. 82.3 Million USD 100.0%
Actinium Pharmaceuticals, Inc. 1.57 Million USD 100.0%
Azitra, Inc. 563.69 Thousand USD 100.0%
Can-Fite BioPharma Ltd. 13 Thousand USD 100.0%
Chromocell Therapeutics Corporation - USD NaN%
Calidi Biotherapeutics, Inc. 2.06 Million USD 100.0%
CEL-SCI Corporation 11.6 Million USD 100.0%
iBio, Inc. 3.5 Million USD 100.0%
Lineage Cell Therapeutics, Inc. 2.07 Million USD 100.0%
MAIA Biotechnology, Inc. - USD NaN%
Matinas BioPharma Holdings, Inc. 2.89 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD 100.0%
NovaBay Pharmaceuticals, Inc. 1.1 Million USD 100.0%
NanoViricides, Inc. - USD NaN%
BiomX Inc. 5.4 Million USD 100.0%
BiomX Inc. 5.4 Million USD 100.0%
Protalix BioTherapeutics, Inc. 4.62 Million USD 100.0%
Palatin Technologies, Inc. 163.78 Thousand USD 100.0%
Scorpius Holdings, Inc. 12.61 Million USD 100.0%
Theriva Biologics, Inc. 162 Thousand USD 100.0%